Singulus Technologies (SNG) Q2 2025 earnings summary

Executive summary

• Sales for H1 2025 were €31.3 million, down from €40.7 million year-over-year, with Q2 sales at €14.9 million versus €20.1 million last year.

• EBIT for H1 2025 was negative at €-1.3 million (prior year: €1.2 million), with a gross margin stable at 31.9%.

• Order intake dropped sharply to €21.1 million (prior year: €52.3 million), while order backlog was €67.2 million, slightly below last year.

• Cash and cash equivalents declined to €5.9 million from €11.3 million at year-end 2024.

• The company expects a significant increase in sales and earnings in H2 2025, driven by new orders and higher capacity utilization.

Financial highlights

• Revenue by segment for H1 2025: Solar €9.0 million (down from €24.0 million), Life Science €10.2 million (down from €11.1 million), Semiconductor €12.1 million (up from €5.6 million).

• EBIT by segment: Solar €-2.7 million, Life Science €-0.7 million, Semiconductor €2.1 million.

• Gross margin for H1 2025 was 31.9% (prior year: 31.8%).

• Operating expenses for H1 2025 were €11.3 million (prior year: €11.7 million).

• Net loss for H1 2025 was €-2.1 million (prior year: €-0.2 million).

Outlook and guidance

• Management expects a significant improvement in sales and earnings in H2 2025, supported by upcoming shipments and new orders.

• Geopolitical and trade policy uncertainties, especially between the US, China, and Europe, may impact project timing and execution.

• The Solar segment is expected to remain the largest contributor to sales and earnings.